Krsnaa Diagnostics' shares surged to a new 52-week high of ₹901.10 on October 11, climbing over 3% after the company secured two major projects to provide radiology and pathology services. Investors are keen on Krsnaa Diagnostics, making it an attractive opportunity to buy shares online.
Positive market momentum for Krsnaa Diagnostics
By 09:20 am on October 11, Krsnaa Diagnostics' stock was trading at ₹890.05, reflecting a gain of ₹29.55 or 3.43% on the BSE. This marked the fourth consecutive day of growth, demonstrating strong investor confidence. The company's steady upward trend continues to generate interest, especially for those looking to buy shares online.
New projects drive growth
Krsnaa Diagnostics signed two key agreements that boosted its market performance. The first agreement, signed with the Medical Superintendent of Sadar Hospital, Ranchi, Jharkhand, enables the company to commission, install, operate, and maintain radiology services, including CT and MRI scans, at the hospital under a public-private partnership (PPP). This project presents a strong growth opportunity for the company, making it an ideal time for investors to buy shares online.
The second agreement was signed with the Ranchi Institute of Neuro-Psychiatry & Allied Services (RINPAS), also in Jharkhand. Krsnaa will supply, install, commission, operate, and maintain a radiology centre (CT and MRI) and pathology laboratory services at RINPAS. These projects solidify the company’s presence in the healthcare sector and provide a strong foundation for future growth, further encouraging investors to buy shares online.
Strategic acquisitions bolster future prospects
In addition to its recent project wins, Krsnaa Diagnostics has been expanding its business through strategic acquisitions. In September 2024, the company announced plans to acquire a 23.53% stake in the healthcare start-up Apulki Healthcare.
This acquisition grants Krsnaa Diagnostics exclusive rights to provide diagnostic services through Apulki Healthcare, broadening its market reach. Such strategic moves increase the attractiveness of the company for those looking to buy shares online.
Stock performance: Highs and lows
Krsnaa Diagnostics' stock has been on an upward trajectory. On September 23, 2024, the stock reached a 52-week high of ₹887.95, and earlier in the year, on June 5, it hit a 52-week low of ₹527.55. Currently, the stock is trading 3.09% below its recent 52-week high but remains a remarkable 63.11% above its yearly low.
This performance underscores the company’s resilience and potential for continued growth, making it an appealing choice for those who want to buy shares online.
A strong investment opportunity
Krsnaa Diagnostics' recent project wins, strategic acquisitions, and impressive stock performance highlight its potential as a solid investment. The company's ongoing expansion into radiology and pathology services, coupled with its exclusive partnerships, positions it well for future growth.
For android only